China approves Bayer's Asundexian for stroke prevention
The approval covers stroke patients at high risk of another event, while applications are still under review in the United States, Europe and Japan.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 19 of 89
The approval covers stroke patients at high risk of another event, while applications are still under review in the United States, Europe and Japan.
Stocks
The proposed Class C shares would go to existing holders and offer Meta another way to raise capital as its AI investment expands.
Stocks
The Turkish lender secured dollar- and euro-denominated funding, with longer-dated portions earmarked for eligible sustainable finance projects.
Stocks3 sources
Three brokerages raised their price targets after Coforge reported higher quarterly profit, while its shares moved sharply during Monday trading.
Stocks
Internal usage measures show fewer app-opening days and less viewing per customer, even as Netflix’s total watch time increased.
Stocks2 sources
The company lowered its revenue growth range after quarterly profit missed analyst estimates, while brokerages differed on the shares.
Stocks2 sources
The chipmaker plans to outline shareholder return measures Wednesday after a report that it is weighing a 16 trillion won special dividend.
Stocks2 sources
The Singapore energy group reported lower first-half earnings as Indonesia began cutting natural gas exports to Singapore.
Stocks
The companies will complete four offshore rigs, with the drillship and jackup expected to be delivered in 2027 and 2028.
Stocks
SAFFRON found longer progression-free and overall survival with savolitinib plus osimertinib than with chemotherapy in a defined lung cancer group.
Stocks
The company withdrew the CEO incentive approval proposal and said directors will take a voluntary fee reduction after project delays.
Stocks
The bank wants most or potentially all planned cost savings in place by 2028, and sees scope to exceed its TSB target.
Stocks
The phase III study found improved survival and slower disease progression with Roche’s investigational drug than with two existing treatments.
Stocks
A senior creditor group is working with PJT Partners as JetBlue pursues a financial and operational overhaul, according to a report.
Stocks
The Phase 3 study found no significant progression-free survival benefit, while its key secondary endpoint showed improved overall survival.
Stocks
The Swiss Bank Employees Association says a relocation, sale or merger could put 10,000 to 12,000 UBS jobs in Switzerland at risk.
Stocks2 sources
Nearly four years of follow-up showed a larger reported overall-survival benefit, while exploratory analyses found disease-free survival gains across baseline MRD groups.
Stocks
The additional payment to Yeni Mağazacılık brings Sabancı Holding’s total payments tied to its CarrefourSA exit to 91 million 949 thousand 568 dollars.
Stocks
The combination produced a 36.7% confirmed response rate and median progression-free survival of 6.9 months in an early Phase 2 study.
Stocks2 sources
United Steelworkers Local 7619 started strike action at the British Columbia site, where operations are continuing at reduced capacity.
Stocks
A late-stage study found the drug combination lowered the risk of death and extended median survival for patients with extensive-stage disease.
Stocks
Credit concerns are testing Nvidia’s financial support for AI infrastructure partners, while its commitments include large guarantees and cloud backstops.
Stocks
The Norwegian fund, which owns about 3% of MPS, plans to vote against several proposals as scrutiny of Intesa’s deal grows.
Stocks
Frasers Group lifted its direct holding in Hugo Boss to 50.08%, crossing the majority threshold with a €7.63 million purchase.
Stocks